Clinical Trials Browser

Gastritis, Atrophic, Gastrointestinal Neoplasms, Influenza, Human, Liver Cirrhosis, Liver Neoplasms, Pancreatic Neoplasms, Peptic Ulcer, Stomach Neoplasms, Tuberculosis, Colorectal Neoplasms, Inflammatory Bowel Diseases, Pancreatitis, Chronic

NCT03250091 2018-08-21

Surveillance of Patients With Precancerous Lesions of the Stomach

Recruiting

2,000 enrolled

Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

NCT01821196 2018-03-12

Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma

Phase NA Withdrawn

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT00397904 2015-11-25

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Phase 2 Completed

16 enrolled 6 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Clinical Trials

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study

OPPOSITE

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

VOLGACORE

Volatolome

Surveillance of Patients With Precancerous Lesions of the Stomach

Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin